Streamlining drug approval
Two of the guys from Drugwonks have written an interesting article in the Washington Times about the Critical Path Initiative that they talk about quite often. I don't take issue with anything specifically in the article, because it's a topic I know next to nothing about. (Though I'm thinking I should learn more…)
It's simply not true that more studies make safer medicines. Over the past 40 years, the percent of medicines withdrawn from the market because of dangerous side effects has been essentially constant at about 2 or 3 percent, even as the number of required clinical studies — a current average of 120 per drug approval — has mushroomed.
The article only take about 5 minutes to read, and it's quite thought-provoking.
Via Drugwonks.
No Comments »
No comments yet.
RSS feed for comments on this post.
| TrackBack URI
You can also bookmark
this on del.icio.us or check the cosmos